These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21560104)

  • 1. [Screening for colorectal cancer: a cost benefit analysis on a health prevention programme at the Boehringer Ingelheim Company].
    Schneider M; Häck HJ
    Dtsch Med Wochenschr; 2011 May; 136(20):1047-52. PubMed ID: 21560104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Precautions for intestinal cancer in the workplace. An initiative for secondary prevention in the BASF joint-stock company].
    Webendörfer S; Messerer P; Eberle F; Zober A
    Dtsch Med Wochenschr; 2004 Feb; 129(6):239-43. PubMed ID: 14750049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for colorectal cancer: which test can we afford?
    Lansdorp-Vogelaar I; van Ballegooijen M; Kuipers EJ
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S38-40. PubMed ID: 18368641
    [No Abstract]   [Full Text] [Related]  

  • 5. A loss-effectiveness analysis of risk-adapted surveillance after colorectal polypectomy.
    Mansmann U
    Stud Health Technol Inform; 2000; 77():395-8. PubMed ID: 11187582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
    Tscheulin DK; Drevs F
    Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of colorectal cancer screening with computed tomography colonography or fecal blood tests.
    Heresbach D; Chauvin P; Grolier J; Josselin JM
    Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1372-9. PubMed ID: 20802341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early detection of bowel cancer in occupational surveillance examinations: switching from a guaiak-based to an immunochemical fecal occult blood test].
    Webendörfer S; Riemann JF
    Dtsch Med Wochenschr; 2014 Jan; 139(3):79-83. PubMed ID: 24089288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The case for population-based screening for colorectal cancer.
    Schoen RE
    Nat Rev Cancer; 2002 Jan; 2(1):65-70. PubMed ID: 11902587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choice of screening modality in a colorectal cancer education and screening program for the uninsured.
    Sarfaty M; Feng S
    J Cancer Educ; 2006; 21(1):43-9. PubMed ID: 16918290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is virtual colonoscopy a cost-effective option to screen for colorectal cancer?
    Sonnenberg A; Delcò F; Bauerfeind P
    Am J Gastroenterol; 1999 Aug; 94(8):2268-74. PubMed ID: 10445561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis of colorectal carcinoma. An update].
    Schneider AR; Caspary WF
    Radiologe; 2003 Feb; 43(2):105-12. PubMed ID: 12624667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness and costs of screening colonoscopy].
    Neuhaus H
    Fortschr Med; 1995 Sep; 113(27):381-4. PubMed ID: 7498861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surveillance and cost-effectiveness of colonoscopy in asymptomatic increased risk subjects of colorectal cancer: Ferrara experience].
    Matarese V; Pezzoli A; Trevisani L; Boccia S; Brancaleoni M; Simone L; Feo C; Gullini S
    Recenti Prog Med; 2004; 95(7-8):352-7. PubMed ID: 15303544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-saving analysis of screening colonoscopy in Germany.
    Sieg A; Brenner H
    Z Gastroenterol; 2007 Sep; 45(9):945-51. PubMed ID: 17874356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, effectiveness and cost-effectiveness of endoscopic screening methods.
    Brenner H
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S20-2. PubMed ID: 18368634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling future capacity needs and spending on colonoscopy in the English bowel cancer screening programme.
    Nnoaham KE; Lines C
    Gut; 2008 Sep; 57(9):1238-45. PubMed ID: 18441004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing risks and benefits of colorectal cancer screening in elderly patients.
    Ko CW; Sonnenberg A
    Gastroenterology; 2005 Oct; 129(4):1163-70. PubMed ID: 16230070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening of colorectal cancer: indications and recommendations for a practical procedure].
    Porschen R
    Z Arztl Fortbild (Jena); 1993 Sep; 87(9):705-10. PubMed ID: 8237065
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness of colon cancer screening.
    Lieberman D
    Am J Gastroenterol; 1991 Dec; 86(12):1789-94. PubMed ID: 1962624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.